Please use this identifier to cite or link to this item:
|Title:||CHA2 DS2 -VASc score as a predictor of adverse outcomes in patients undergoing percutaneous coronary intervention (PCI).|
|Conference Name:||65th Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research Australasian Section Annual Scientific Meeting.|
|Conference Date:||August 10th- 13th|
|Conference Place:||Perth, Australia|
|Abstract:||Introduction : CHA 2 DS 2 -VASc score is validated in predicting stroke risk in AF and provides a guide for management. We evaluated the use of CHA 2 DS 2 -VASc score in all-comers to predict mortality in patients undergoing PCI. Methods : CHA 2 DS 2 -VASc score was calculated on 18,818 patients undergoing PCI across 6 centres from 2005-2013. Clinical and procedural data, 30-day, 1-year and long-term outcomes were compared between the groups. Those with out-of-hospital cardiac arrest, cardiogenic shock and incomplete data set were excluded. NDI linked long-term follow-up was 3.44 ± 1.97 years.|
|Internal ID Number:||01301|
|Health Subject:||STROKE RISK PREDICTION|
MORTALITY RATE PREDICTION
|Appears in Collections:||Research Output|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.